During the past decade, Fakultna nemocnica Trencin Ocna klinika conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fakultna nemocnica Trencin Ocna klinika" are "Diabetic Macular Edema" (2 trials) and "Geographic Atrophy" (2 trials). Many other conditions were trialed in "Fakultna nemocnica Trencin Ocna klinika" in a lesser frequency.

Most popular intervention types in "Fakultna nemocnica Trencin Ocna klinika" are "Drug" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Lampalizumab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials) and "Sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fakultna nemocnica Trencin Ocna klinika" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Fakultna nemocnica Trencin Ocna klinika". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fakultna nemocnica Trencin Ocna klinika, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultna nemocnica Trencin Ocna klinika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".